Publications

5891 Results

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

Authors
J Brown;C Ma;D Niedzwiecki;T Zemla;F Couture;P Kuebler;P Kumar;J Hopkins;B Tan;S Krishnamurthi;E O'Reilly;A Shields;J Meyerhardt
Journal / Conference
Br J Sports Med. Aug;57(15):965-971
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36878665
PMC
PMC19423490
Study Number(s)
CTSU/C80702

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Authors
Q Wang;C Ma;Q Shi;B Wolpin;Y Zhang;C Fuchs;J Meyer;T Zemla;P Kumthekar;K Guthrie;F Couture;P Kuebler;P Kumar;B Tan;S Krishnamurthi;R Goldberg;A Venook;C Blanke;A Shields;E O'Reilly;J Meyerhardt;K Ng
Journal / Conference
CLINICAL CANCER RESEARCH
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37289007
PMC
PMC10524689
Study Number(s)
CTSU/C80702

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials

Authors
C Gallois;Q Shi;J Meyers;T Iveson;S Alberts;A De Gramont;A Sobrero;D Haller;E Oki;A Shields;R Goldberg;R Kerr;S Lonardi;G Yothers;C Kelly;I Boukovinas;R Labianca;F Sinicrope;I Souglakos;T Yoshino;J Meyerhardt;T Andre;D Papamichael;J Taieb
Journal / Conference
Journal of Clinical Oncology 2023 Feb 1;41(4):803-815. doi: 10.1200/JCO.21.02726. Epub 2022 Oct 28.
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID38547438
Study Number(s)
CTSU/C80702

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Authors
P Kunz;N Graham;P Catalano;H Nimeri;G Fisher;T Longacre;C Suarez;B Martin;J Yao;M Kulke;A Hendifar;J Shanks;M Shah;M Zalupski;E Schulbach;D Reidy-Lagunes;J Strosberg;P O'Dwyer;A Benson
Journal / Conference
Journal of Clinical Oncology
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36260828
PMC
PMC9995105
Study Number(s)
CTSU/E2211

Geriatric Assessment measures are predictive of outcomes in chronic lymphocytic leukemia

Authors
P Johnson;J Woyach;A Ulrich;V Marcotte;R Nipp;D Lage;A Nelson;R Newcomb;J Rice;M Lavoie;C Ritchie;R Stone;A Ruppert;S Mandrekar;J Byrd;A El-Jawahri;J Le-Rademacher;A Rosko;D Stephens
Journal / Conference
Journal of Geriatric Oncology
Year
2023
Research Committee(s)
Leukemia
PMID
PMID37329769
Study Number(s)
CTSU/A041202

Ability to Eat among Cancer Patients Treated for Malignant Bowel Obstruction: A Secondary Analysis within SWOG S1316

Authors
C Thomson;G Anderson;K Arnold;V Sun;R Krouse
Journal / Conference
ASPO Annual Meeting (March 12-14, 2023, San Diego, CA)
Year
2023
Research Committee(s)
Palliative Care
Study Number(s)
S1316

[CTP] TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) with or without durvalumab vs investigator's choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy

Authors
A Bardia;L Pusztai;K Albain;K Kalinsky;D Hershman;W Barlow;E Tokunaga;J Wu;S Im;E Ciruelos;D Loirat;C Isaacs;L Testa;H Dry;R Zozarski;M Maxwell;N Harbeck;P Sharma
Journal / Conference
St. Gallen International Breast Cancer Conference (March 15-18, 2023; St. Gallen, Switzerland), e-poster
Year
2023
Research Committee(s)
Breast

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 AML risk stratifications: A SWOG report

Authors
C Termini;A Moseley;M Othus;F Appelbaum;T Chauncey;H Erba;M Fang;S Lee;J Naru;E Pogosova- Agadjanyan;J Radich;C Willman;F Wu;S Meshinchi;D Stirewalt
Journal / Conference
Haematologica. Apr 6. doi: 10.3324/haematol.2023.282733. Online ahead of print
Year
2023
Research Committee(s)
Leukemia
PMID
PMID37021537
PMC
PMC Journal - In Process
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R

Authors
R Lakhotia;K Dunleavy;J Abramson;B Link;B Powell;C Melani;N Lucas;S Steinberg;JW Friedberg;B Kahl;R Little;N Bartlett;A Noy;W Wilson;M Roschewski
Journal / Conference
Blood Advances Jun 30;bloodadvances.2023010223. doi: 10.1182/bloodadvances.2023010223. Online ahead of print
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID37389844
Study Number(s)
CTSU/9177

The new NCI precision medicine Trials

Authors
L Harris;CD Blanke;HP Erba;J Ford;R Gray;ML LeBlanc;S Hu-Lieskovan;M Litzow;S Luger;F Meric-Bernstam;P O'Dwyer;M Othus;K Politi;L Shephard;C Allegra;H Chen;SP Ivy;L Korde;R Little;L McShane;J Moscow;D Patton;M Thurin;L Yee;J Doroshow
Journal / Conference
CLINICAL CANCER RESEARCH
Year
2023
Research Committee(s)
Leukemia
PMID
PMID: 37531248
PMC
PMC10690084
Study Number(s)
MYELOMATCH